Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Georgios F Nikolaidis

Showing results (11-20 of 14) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 14 results.
Advances in Therapy|December 3, 2025
Comparative Efficacy and Safety of Tislelizumab in Second-Line Esophageal Squamous Cell Carcinoma: Systematic Literature Review and Simulated Treatment ComparisonsJaffer A Ajani, Kaijun Wang, Georgios F Nikolaidis, et al.
Lung Cancer (Amsterdam, Netherlands)|February 22, 2025
Comparative effectiveness and safety of tislelizumab versus other anti-PD-(L)1 agents in first- and subsequent lines in locally advanced or metastatic non-small cell lung cancer: Systematic literature review and network meta-analysisNicolas Girard, Ji-Youn Han, Ross A Soo, et al.
Health Research Policy and Systems|March 23, 2024
Multimorbidity healthcare expenditure in Belgium: a 4-year analysis (COMORB study)Phuong Bich Tran, Georgios F Nikolaidis, Emmanuel Abatih, et al.
BMJ Global Health|May 23, 2022
TB morbidity estimates overlook the contribution of post-TB disability: evidence from urban MalawiEwan M Tomeny, Rebecca Nightingale, Beatrice Chinoko, et al.
Pageof 2

Showing results (11-20 of 14) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 14 results.
Advances in Therapy|December 3, 2025
Comparative Efficacy and Safety of Tislelizumab in Second-Line Esophageal Squamous Cell Carcinoma: Systematic Literature Review and Simulated Treatment ComparisonsJaffer A Ajani, Kaijun Wang, Georgios F Nikolaidis, et al.
Lung Cancer (Amsterdam, Netherlands)|February 22, 2025
Comparative effectiveness and safety of tislelizumab versus other anti-PD-(L)1 agents in first- and subsequent lines in locally advanced or metastatic non-small cell lung cancer: Systematic literature review and network meta-analysisNicolas Girard, Ji-Youn Han, Ross A Soo, et al.
Health Research Policy and Systems|March 23, 2024
Multimorbidity healthcare expenditure in Belgium: a 4-year analysis (COMORB study)Phuong Bich Tran, Georgios F Nikolaidis, Emmanuel Abatih, et al.
BMJ Global Health|May 23, 2022
TB morbidity estimates overlook the contribution of post-TB disability: evidence from urban MalawiEwan M Tomeny, Rebecca Nightingale, Beatrice Chinoko, et al.
Pageof 2